Market Place
Sourcing Support
All News #Library
Sciences
TScan Named Top Place to Work by Boston Globe for 3 Years
05 Dec 2024 //
GLOBENEWSWIRE
TScan Gets FDA RMAT For Lead TCR-T Candidates In Heme Malignancies
29 May 2024 //
GLOBENEWSWIRE
TScan First Patient Dosed In Solid Tumor TCR-T Trial
09 May 2024 //
GLOBENEWSWIRE
TScan Announces Underwriters` Option Exercise
24 Apr 2024 //
GLOBENEWSWIRE
TScan Provides Clinical Pipeline Update, Highlights Near-Term Priorities
16 Apr 2024 //
GLOBENEWSWIRE
TScan to Discuss Results from Phase 1 Heme Malignancies Study Presented
14 Feb 2024 //
GLOBENEWSWIRE
TScan Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101
09 Dec 2023 //
GLOBENEWSWIRE
TScan Named Top Place to Work by The Boston Globe for Two Consecutive Years
30 Nov 2023 //
PRESS RELEASE
TScan Presents Preliminary Phase 1 Clinical Results on TSC-100 and TSC-101
17 May 2023 //
GLOBENEWSWIRE
Amgen enlists TScan to work on Crohn`s in deal potentially worth $500M+
10 May 2023 //
ENDPTS
Amgen & TScan Announce Collab to Identify Novel Targets in Crohn™s Disease
09 May 2023 //
GLOBENEWSWIRE
TScan Announces Upcoming Trial in Progress Poster Presentation at the ASGCT
02 May 2023 //
GLOBENEWSWIRE
TScan Announces First Patient Dosed in PI Trial Evaluating TSC-100 and TSC-101
14 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.